Last reviewed · How we verify
periarticular injection of multidrug regimen
periarticular injection of multidrug regimen is a Small molecule drug developed by Chung-Ang University Hosptial, Chung-Ang University College of Medicine. It is currently FDA-approved. Also known as: injection near the hip joint.
At a glance
| Generic name | periarticular injection of multidrug regimen |
|---|---|
| Also known as | injection near the hip joint |
| Sponsor | Chung-Ang University Hosptial, Chung-Ang University College of Medicine |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- periarticular injection of multidrug regimen CI brief — competitive landscape report
- periarticular injection of multidrug regimen updates RSS · CI watch RSS
- Chung-Ang University Hosptial, Chung-Ang University College of Medicine portfolio CI
Frequently asked questions about periarticular injection of multidrug regimen
What is periarticular injection of multidrug regimen?
periarticular injection of multidrug regimen is a Small molecule drug developed by Chung-Ang University Hosptial, Chung-Ang University College of Medicine.
Who makes periarticular injection of multidrug regimen?
periarticular injection of multidrug regimen is developed and marketed by Chung-Ang University Hosptial, Chung-Ang University College of Medicine (see full Chung-Ang University Hosptial, Chung-Ang University College of Medicine pipeline at /company/chung-ang-university-hosptial-chung-ang-university-college-of-medicine).
Is periarticular injection of multidrug regimen also known as anything else?
periarticular injection of multidrug regimen is also known as injection near the hip joint.
What development phase is periarticular injection of multidrug regimen in?
periarticular injection of multidrug regimen is FDA-approved (marketed).
Related
- Manufacturer: Chung-Ang University Hosptial, Chung-Ang University College of Medicine — full pipeline
- Also known as: injection near the hip joint
- Compare: periarticular injection of multidrug regimen vs similar drugs
- Pricing: periarticular injection of multidrug regimen cost, discount & access